Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/192186
Title: Predictive factors for resection and survival in type A borderline resectable pancreatic ductal adenocarcinoma patients after neoadjuvant therapy: A retrospective cohort study
Author: Secanella, Luis
Busquets, Juli
Peláez, Núria
Sorribas, María
Laquente, Berta
Ruiz, Sandra
Carnaval, Thiago
Videla, Sebastián
Fabregat, Juan
Keywords: Càncer de pàncrees
Cirurgia
Tractament adjuvant del càncer
Pancreas cancer
Surgery
Adjuvant treatment of cancer
Issue Date: 2-Dec-2022
Publisher: Ovid Technologies (Wolters Kluwer Health)
Abstract: Introduction:Pancreatic cancer is the seventh leading cause of cancer-related death worldwide, and surgical resection with radical intent remains the only potentially curative treatment option today. However, borderline resectable pancreatic ductal adenocarcinomas (BR-PDAC) stand in the gray area between the resectable and unresectable disease since they are technically resectable but have a high probability of incomplete exeresis. Neoadjuvant treatment (NAT) plays an important role in ensuring resection success.Different survival prognostic factors for BR-PDAC have been well described, but evidence on the predictive factors associated with resection after NAT is scarce. This study aims to study if CA 19-9 plasmatic levels and the tumor anatomical relationship with neighboring vascular structures are prognostic factors for resection and survival (both Overall Survival and Progression-Free Survival) in patients with type A BR-PDAC. Methods:This will be a retrospective cohort study using data from type A BR-PDAC patients who received NAT in the Bellvitge University Hospital. The observation period is from January 2010 until December 2019; patients must have a minimum 12-month follow-up. Patients will be classified according to the MD Anderson Cancer Center criteria for BR-PDAC. Discussion:Patients with BR-PDAC have a high risk for a margin-positive resection. Serum Carbohydrate Antigen 19-9 plasmatic levels and vascular involvement stand out as disease-related prognostic factors.This study will provide valuable information on the prognostic factors associated with resection. We will exclude locally advanced tumors and expect this approach to provide more realistic resection rates without selecting those patients that undergo surgical exploration. However, focusing on an anatomical definition may limit the results' generalizability.
Note: Reproducció del document publicat a: https://doi.org/10.1097/MD.0000000000032126
It is part of: Medicine, 2022, vol. 101, num. 48, p. e32126
URI: http://hdl.handle.net/2445/192186
Related resource: https://doi.org/10.1097/MD.0000000000032126
ISSN: 1536-5964
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
Predictive_factors_for_resection_and_survival_in.125.pdf530.26 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons